[Histamine H2 receptor blockaders: possibilities and prognosis in the use of stage III-IV preparations in the therapy of internal diseases].
L P
LP
Miagkova
A L
AL
Grebenev
A M
AM
Kkhorshed
D002927:Cimetidine / Q000009:adverse effects / Q000494:pharmacology; D015738:Famotidine / Q000494:pharmacology / Q000627:therapeutic use; D005744:Gastric Acid / Q000378:metabolism*; D006635:Histamine H2 Antagonists / Q000627:therapeutic use*; D006801:Humans; D010437:Peptic Ulcer / Q000188:drug therapy* / Q000503:physiopathology; D011899:Ranitidine / Q000494:pharmacology* / Q000627:therapeutic use
D006635:Histamine H2 Antagonists; D015738:Famotidine; D002927:Cimetidine; D011899:Ranitidine
Blokatory H2--retseptorov gistamins: vozmozhnosti i perspektivy primenenia v klinike vnutrennikh bolezneĭ preparatov III-IV pokoleniĭ.